Contribute
España
Italia
대한민국
日本
Français
Benzinga
Research
My Stocks
Tools
Free Benzinga Pro Trial
SPY
764.440.02%
QQQ
715.040.02%
BTC/USD
77791.981.2918%
DIA
525.910.02%
GLD
398.290.12%
TLT
80.930.07%

Vivos Therapeutics Inc (VVOS) Stock Price, Quote, News & History

VVOSNASDAQ
Trade with Public
Trade with Public
$0.1840
0.00241.32%
At close: Sep 11, 5:00 PM EST
$0.1761
-0.0079-4.29%
After Hours: Sep 11, 7:56 PM EST
OverviewNewsEarnings ForecastEventsPrice TargetsFinancialsSentimentOwnershipCompareStock Report

Vivos Therapeutics (VVOS) Stock Price, Quote, News & History | Benzinga

Key Statistics

Open
$0.18
Close
$0.18
Volume / Avg.
1.52M / 11.34M
Day Range
$0.18 - $0.19
52 Wk Range
0.16 - 3.98
Market Cap
$3.54M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
30
Short Interest
14.43%
Days to Cover
1

Recent Vivos Therapeutics Inc News

Why Pyxis Tankers Shares Are Trading Higher By Over 11%; Here Are 20 Stocks Moving Premarket

Shares of Pyxis Tankers Inc (NASDAQ:PXS) rose sharply in pre-market trading after the company reported better-than-expected earnings for the second quarter. The company posted quarterly earnings of 27 cents per
Avi Kapoor

Dow Falls Over 300 Points; SAIC Shares Jump After Upbeat Q2 Results

U.S. stocks traded lower this morning, with the Dow Jones index falling more than 300 points on Monday. Following the market opening Monday, the Dow traded down 0.61% to 53,232.50 while the NASDAQ slipped 0.45% to
Avi Kapoor

Why Webuy Global Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket

Shares of Webuy Global Ltd (NASDAQ:WBUY) rose sharply in pre-market trading. Webuy reported record preliminary unaudited travel bookings of around $4.76 million during the three-day NATAS Fair in Aug. 2026,
Avi Kapoor

Why Arista Networks Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket

Arista Networks Inc (ANET) reported strong Q2 results, with revenue of $3.04B, up 37.7% YoY. Shares rose 13% in pre-market trading.
Avi Kapoor

Vivos Extends Streeterville Financing Deal Through Aug. 31, Reaffirms Plan To Convert Up To $4.5M Debt Into Preferred And Common Stock

Vivos Therapeutics, Inc. ("Vivos" or the "Company") (NASDAQ:VVOS), a leading medical device and healthcare services company focused on the treatment of breathing-related sleep disorders and associated
Benzinga News-desk

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-17.13M
Investing Cash Flow (TTM)
-1.93M
Financing Cash Flow (TTM)
16.43M
Free Cash Flow (TTM)
-19.01M
Capital Expenditure (TTM)
-1.88M
Net Change in Cash (TTM)
-2.63M

Analyst Trends and Forecast

2
Apr
1
Jun
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.0
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$15.54M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
0.12
PB Ratio (TTM)
-
Earnings Yield % (TTM)
-1035.24%
Earnings Yield % (FWD)
-110.13%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
-$0.24

Company Debt

Total Debt
$8.14M
LT Debt
$366.00K
LT Debt Issuance (TTM)
$4.06M
LT Debt Repayment (TTM)
-$1.28M
Total Cash
$1.77M
Debt to Equity
-
Issuance of Debt (TTM)
$2.78M
Repayment of Debt (TTM)
-$1.28M

Key Statistics

Open
$0.18
Close
$0.18
Volume / Avg.
1.52M / 11.34M
Day Range
$0.18 - $0.19
52 Wk Range
0.16 - 3.98
Market Cap
$3.54M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
30
Short Interest
14.43%
Days to Cover
1

About

Sector
Health Care
Industry
Health Care Providers & Services
Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Vivos Therapeutics (VVOS) stock?

A

You can purchase shares of Vivos Therapeutics (NASDAQ:VVOS) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Vivos Therapeutics (VVOS) competitors?

Q

What is the forecast, or price target, for Vivos Therapeutics (VVOS) stock?

A

Vivos Therapeutics has a consensus price target of $3.87.

Q

What is the current price for Vivos Therapeutics (VVOS)?

A

The stock price for Vivos Therapeutics (NASDAQ: VVOS) is $0.1761 last updated September 11, 2026 at 7:56 PM EDT.

Q

Does Vivos Therapeutics (VVOS) pay a dividend?

A

There are no upcoming dividends for Vivos Therapeutics.

Q

When is Vivos Therapeutics (NASDAQ:VVOS) reporting earnings?

A

Vivos Therapeutics does not have any upcoming earnings scheduled.

Q

Is Vivos Therapeutics (VVOS) going to split?

A

There is no upcoming split for Vivos Therapeutics.

Q

What sector and industry does Vivos Therapeutics (VVOS) operate in?

A

Vivos Therapeutics is in the Health Care sector and Health Care Providers & Services industry. They are listed on the NASDAQ.

Data & APIs: Benzinga APIs · Stock News API · Analyst Ratings API · Company Logo API

Market data provided by Benzinga APIs

Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved